Literature DB >> 21058161

Variability in anxiety and depression over time following diagnosis in patients with prostate cancer.

Christopher F Sharpley1, David R H Christie, Vicki Bitsika.   

Abstract

To determine the presence and nature of variability in anxiety and depression in patients with prostate cancer (PCa) over 3 years following diagnosis, 442 patients with PCa completed standardized anxiety and depression inventories via survey between 1 and 36 months after receiving their initial diagnosis. Data were analyzed from a series of 3-month cohorts, and results indicated that total scores and incidence of clinically significant anxiety and depression varied over time, but that this variability was restricted to specific subfactors of anxiety and depression. Provision of effective psychological treatment to patients with PCa is discussed.

Entities:  

Mesh:

Year:  2010        PMID: 21058161     DOI: 10.1080/07347332.2010.516810

Source DB:  PubMed          Journal:  J Psychosoc Oncol        ISSN: 0734-7332


  8 in total

Review 1.  The impact of prostate biopsy on urinary symptoms, erectile function, and anxiety.

Authors:  Alexander P Glaser; Kristian Novakovic; Brian T Helfand
Journal:  Curr Urol Rep       Date:  2012-12       Impact factor: 3.092

2.  Cross-cultural differences in men on active surveillance' anxiety: a longitudinal comparison between Italian and Dutch patients from the Prostate cancer Research International Active Surveillance study.

Authors:  Paola Dordoni; Sebastiaan Remmers; Riccardo Valdagni; Lara Bellardita; Letizia De Luca; Fabio Badenchini; Cristina Marenghi; Monique J Roobol; Lionne D F Venderbos
Journal:  BMC Urol       Date:  2022-07-18       Impact factor: 2.090

3.  Randomized, double-blind, placebo-controlled study of methylphenidate for the treatment of depression in SSRI-treated cancer patients receiving palliative care.

Authors:  Donald R Sullivan; Solange Mongoue-Tchokote; Motomi Mori; Elizabeth Goy; Linda Ganzini
Journal:  Psychooncology       Date:  2016-08-12       Impact factor: 3.894

4.  Do hormone treatments for prostate cancer cause anxiety and depression?

Authors:  Christopher F Sharpley; David R H Christie; Vicki Bitsika
Journal:  Int J Clin Oncol       Date:  2013-06-01       Impact factor: 3.402

5.  The role of Melancholia in prostate cancer patients' depression.

Authors:  Christopher F Sharpley; Vicki Bitsika; David R Christie
Journal:  BMC Psychiatry       Date:  2011-12-20       Impact factor: 3.630

6.  Anxiety and Depression in Patients with Prostate Cancer, at Cancer Diagnosis and after a One-Year Follow-Up.

Authors:  Vítor Duarte; Natália Araújo; Catarina Lopes; Adriana Costa; Augusto Ferreira; Filipa Carneiro; Jorge Oliveira; Isaac Braga; Samantha Morais; Luís Pacheco-Figueiredo; Luis Ruano; Vítor Tedim Cruz; Susana Pereira; Nuno Lunet
Journal:  Int J Environ Res Public Health       Date:  2022-07-26       Impact factor: 4.614

7.  The Anxiety Depression Pathway Among Men Following a Prostate Cancer Diagnosis: Cross-Sectional Interactions Between Anger Responses and Loneliness.

Authors:  Simon M Rice; David Kealy; John S Ogrodniczuk; Zac E Seidler; Gabriela Montaner; Suzanne Chambers; John L Oliffe
Journal:  Am J Mens Health       Date:  2021 May-Jun

8.  Mode of prostate cancer detection is associated with the psychological wellbeing of survivors: results from the PiCTure study.

Authors:  Frances J Drummond; Eamonn O'Leary; Anna Gavin; Heather Kinnear; Linda Sharp
Journal:  Support Care Cancer       Date:  2015-11-23       Impact factor: 3.359

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.